Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OLANZAPINE Cause Myocardial infarction? 184 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 184 reports of Myocardial infarction have been filed in association with OLANZAPINE (Olanzapine). This represents 0.4% of all adverse event reports for OLANZAPINE.

184
Reports of Myocardial infarction with OLANZAPINE
0.4%
of all OLANZAPINE reports
40
Deaths
76
Hospitalizations

How Dangerous Is Myocardial infarction From OLANZAPINE?

Of the 184 reports, 40 (21.7%) resulted in death, 76 (41.3%) required hospitalization, and 30 (16.3%) were considered life-threatening.

Is Myocardial infarction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OLANZAPINE. However, 184 reports have been filed with the FAERS database.

What Other Side Effects Does OLANZAPINE Cause?

Drug ineffective (5,139) Weight increased (3,588) Off label use (3,256) Toxicity to various agents (3,175) Somnolence (2,612) Sedation (2,130) Suicide attempt (2,116) Confusional state (1,898) Condition aggravated (1,810) Overdose (1,765)

What Other Drugs Cause Myocardial infarction?

ROSIGLITAZONE (17,018) TESTOSTERONE (3,396) ADALIMUMAB (3,214) SACUBITRIL\VALSARTAN (3,120) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (2,391) APIXABAN (2,010) TICAGRELOR (1,749) LENALIDOMIDE (1,712) ETANERCEPT (1,693) METFORMIN\ROSIGLITAZONE (1,640)

Which OLANZAPINE Alternatives Have Lower Myocardial infarction Risk?

OLANZAPINE vs OLANZAPINE\SAMIDORPHAN L-MALATE OLANZAPINE vs OLAPARIB OLANZAPINE vs OLARATUMAB OLANZAPINE vs OLECLUMAB OLANZAPINE vs OLIVE OIL\SOYBEAN OIL

Related Pages

OLANZAPINE Full Profile All Myocardial infarction Reports All Drugs Causing Myocardial infarction OLANZAPINE Demographics